Rectal Cancer Risk After Colectomy in Patients With Inflammatory Bowel Disease-A Population-Based Danish Cohort Study...

Area of Science:

• Gastroenterology
• Oncology
• Epidemiology

Background:

• Patients with ulcerative colitis and Crohn's disease have a higher risk of colorectal cancer.
• Current surveillance guidelines for colorectal cancer often do not include patients who have undergone colectomy.
• There is a need to understand the specific risk of rectal cancer in inflammatory bowel disease (IBD) patients after subtotal colectomy.

Purpose of the Study:

• To estimate the risk of developing rectal cancer in patients with IBD after subtotal colectomy.
• To compare this risk against IBD patients without colectomy and the general population.

Main Methods:

• A nationwide population-based cohort study was conducted using the Danish Civil Registration System.
• Data from 1978 to 2018 were analyzed.
• Cox regression analyses were used to assess rectal cancer risk in patients with a diverted rectum post-colectomy.

Main Results:

• Rectal cancer occurred in 0.9% of patients (42/4931) after subtotal colectomy with a diverted rectum.
• The hazard ratio for rectal cancer was significantly increased 10 years after colectomy (HR 7.56 vs. IBD without colectomy; HR 10.01 vs. background population).
• Before 10 years post-colectomy, the risk was not significantly elevated compared to controls.

Conclusions:

• The risk of rectal cancer in the diverted rectum is markedly increased 10 years after subtotal colectomy in IBD patients.
• This finding underscores the necessity for improved and extended long-term surveillance strategies for IBD patients who have undergone colectomy.
• Current surveillance protocols may be inadequate for this high-risk group.